Behavioral performance effects of antihypertensive drugs: Human and animal studies

Neuroscience and Biobehavioral Reviews

Volumn 12, Issue 2, 1988, Pages 111-122

  Turkkan, Jaylan S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha adrenergic agonists Diuretics; Angiotensin converting enzyme inhibitors; Antihypertensive drugs; Behavioral performance; Calcium channel blockers; Drug compliance; Hypertension treatment; Learning and memory; Psychomotor Reaction time; Side effects; Blockers

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMILORIDE; ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FLUNARIZINE; GUANFACINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; METOPROLOL; NIFEDIPINE; OXPRENOLOL; PINDOLOL; PROPRANOLOL; TIAPAMIL; TIMOLOL; YOHIMBINE;

ANIMAL EXPERIMENT; BEHAVIOR; CALCIUM CHANNEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LEARNING; MEMORY; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMAL; ANTIHYPERTENSIVE AGENTS; BEHAVIOR, ANIMAL; COMPARATIVE STUDY; HUMAN; HYPERTENSION; MENTAL PROCESSES; QUALITY OF LIFE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024156134     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(88)80003-4     Document Type: Article

References (146)

1. Antinociceptive mechanism and acute and chronic behavioral effects of clonidine
2. Drugs Manes took may have emotional effects
3. 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates
4. Clonidine produces a conditioned place preference in rats
5. Tranquillizing effects of propranolol demonstrated in rats
6. The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function
7. Antihypertensive effect and side effects of bendroflumethiazide and propranolol
8. Effects of antihypertensive treatment on cerebral perfusion
9. Atenolol in the central nervous system of monkeys
10. Hemodynamic effects of systemic and central administration of clonidine in the monkey
11. Effects of clonidine on 24-hour hormonal secretory patterns, cardiovascular hemodynamics, and central nervous function in hypertensive adolescents
12. Converting enzyme inhibition with an orally active compound in hypertensive man
13. The effect of propranolol on human psychomotor performance
14. Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity
15. Propranolol on tests of visual function and central nervous activity
16. Neuro-psychiatric effects of adrenergic beta-receptor blocking agents
17. Effect of metoprolol and oxprenolol on delayed differentiation behaviour in the monkey (Macaca mulatta)
18. The psychomotor effects of atenolol and other antihypertensive agents
19. Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers
20. The effects of antihypertensive therapy on the quality of life
21. Discriminative stimulus properties of clonidine: Substitution by ergot derivatives
22. Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats
23. Effects of clonidine and some alpha-adrenoreceptor blocking agents on avoidance conditioned reflexes in rats: Their interactions and antagonism by atropine
24. The clinical use of ACE inhibitors: Quality of life considerations
25. Comparison of yohimbine, mianserin, chlorpromazine and prazosin as antagonists of the suppressant effect of clonidine on operant behavior
26. Tiapamil, a new calcium antagonist
27. Effects of antihypertensive drugs on cognitive function in adolescents
28. Blood pressure and cognitive performance: The Framingham Study
29. A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance
30. Beta-adrenoceptor antagonists: New drugs and new indications
31. Selective impairment of paired associated learning after administration of a centrally-acting adrenergic agonist (clonidine)
32. The effect of β-blockers on mental performance on older hypertensive patients
33. Lipid-soluble and water-soluble β-blockers: Comparison of the central nervous system depressant effect
34. Antimanic effects of verapamil
35. Clinical utility of clonidine in opiate withdrawal: A study of 100 patients
36. Plasma norepinephrine during stress in essential hypertension
37. Plasma norepinephrine in essential hypertension: A study of the studies
38. Determination of the optimal dose of antihypertensive drugs
39. Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study
40. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice
41. Adverse reactions to Beta-adrenergic receptor blocking drugs: A report from the Boston Collaborative drug surveillance program
42. Effects of Alpha-Methyl-Dopa on conditioned behaviour in the cat
43. Influence of the beta-blocker atenolol and other medications on visual reaction time
44. The effect of beta adrenergic blocking drugs on speakers' performance and memory
45. The effects of four antihypertensive agents on the Stroop Colour-Word Test in normal male volunteer subjects
46. Beta-adrenergic blockade in stress protection. Limited effect of metoprolol in psychological stress reaction
47. Adverse reactions to antihypertensive drug therapy: Central nervous system
48. Alpha-Methyldopa and related compounds
49. Verapamil and myoclonic dystonia
50. Behavioral depression following clonidine withdrawal: A new animal model of long-lasting depression?
51. The behavioral side effects of the antihypertensive agents
52. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial
53. Five Year Findings of the Hypertension Detection and Follow-up Program II Mortality by Race-Sex and Age
54. Hypertension prevalence and the status of awareness, treatment and control in the United States: Final Report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee
55. Central mechanisms of clonidine and propranolol in man: Quantitative pharmaco-EEG with antihypertensive compounds
56. Long-term evaluations of therapeutic efficacy and safety of guanfacine
57. Assessment of psychic side-effects of antihypertensive drugs
58. The sleep of artificially reared newborn rats, effect of alpha-methyl-dopa treatment on paradoxical sleep and on adult behaviour
59. Effect of guanfacine on skills related to driving
60. Nifedipine: Kinetics and dynamics in healthy subjects
61. The role of the beta-adrenergic system in behavior: Antidepressant effects of propranolol
62. Central nervous system effects of β-adrenergic blocking drugs: The role of ancillary properties
63. Effects of the training dose on generalization of morphine stimulus to clonidine
64. Differences in psychic performance with guanfacine and clonidine in normotensive subjects
65. Central and peripheral effects of propranolol and sotalol in normal human subjects
66. Psychotropic actions of clonidine
67. Discriminative stimuli produced by clonidine in spontaneously hypertensive rats: Generalization to antihypertensive drugs with different mechanisms of action
68. Propranolol and skilled human performance
69. Effects of atenolol and propranolol on human performance and subjective feelings
70. Alpha-methyl-DOPA disassociates hypertension, cardiovascular reactivity and emotional behavior in spontaneously hypertensive rats
71. Some effects of propranolol on the central nervous system
72. Differential effects of atenolol and enalapril on memory during treatment for essential hypertension
73. Slowing of response time in young and middle-aged hypertensive patients
74. Clonidine analgesia and suppression of operant responding: Dissociation of mechanism
75. Memory enhancement in Korsakoff's psychosis by clonidine: Further evidence for a noradrenergic defect
76. Tolerance to behavioral effects of clonidine after chronic administration of morphine
77. 2-adrenoreceptor antagonism
78. Memory performance by mild hypertensives following beta-adrenergic blockade
79. Cognitive enhancement in Korsakoff's psychosis by clonidine: A comparison with L-Dopa and ephedrine
80. Tolerance and dependence after chronic administration of clonidine to the rat
81. Anti-hypertensive therapy in the elderly and its effects on cerebral function
82. The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension
83. Effect of antihypertensive treatment on the behavioral consequences of elevated blood pressure
84. Central nervous system effects of four β-adrenergic receptor blocking agents
85. Effect of the hypotensive drug ST 155 (cata-press) on the heart and peripheral circulation
86. Behavioral studies in the monkey (macaca mulatta) with sotalol and with (+)-, (+) and (−)-propranolol
87. Angiotensin converting enzyme inhibitors in patients with essential hypertension
88. The clinical pharmacology of antihypertensive drugs
89. The relationship among heart rate, carotoid dp/dt, blood pressure in humans as a function of the type of stress
90. The effects of oral doses of oxprenolol and of propranolol on CNS function in man
91. The effects of high doses of oxprenolol and of propranolol on pursuit motor performance, reaction time and critical flicker frequency
92. Psychotropic effects of enalapril maleate in normal volunteers
93. CNS effects of propranolol in man
94. Disparate effects of initial antihypertensive therapy on well-being
95. Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat
96. Secondary mania associated with diltiazem
97. Side effects of clonidine
98. Morphine-like effects of clonidine on the EEG, slow wave sleep, and behavior in the dog
99. Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats
100. Antinociceptive effects and spinal cord tissue concentrations after intrathecal injection of guanfacine or clonidine into rats
101. Effects of L-Alpha methyl dopa on discrete trial behavior
102. Effects of rapid blood pressure reduction on cerebral blood flow
103. Problems of sexual function in patients with hypertension
104. The past, the present and the future of risks conveyed by antihypertensive treatment: Concluding remarks
105. Calcium channel blockers and hypertension
106. The antihypertensive of captopril in hypertensive animal models
107. Atenolol in the treatment of hypertension: A single-daily dose
108. Central effects of beta-adrenoceptor antagonists
109. Central effect of single oral doses of propranolol in man
110. Effects of propanolol on conditioned suppression, discriminated punishment and discriminated non-reward in the rat
111. Four cases of clonidine abuse
112. Beta-receptor blocking therapy in hypertensive patients—Effects on vigilance and behavior
113. Clonidine induced hyperphagia and weight gain in monkeys
114. The influence of beta blockers on cardiovascular reactivity and type a behavior pattern in hypertensives
115. Animal pharmacology of guanfacine
116. Effects of propranolol and chlordiazepoxide on conflict behavior in rats
117. Self-administration of clonidine by the rat
118. Impairment of memory by antihypertensive medication
119. Clonidine antagonized naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats
120. Prevention and control of hypertension by nutritional-hygienic means. Long-term experience of the Chicago Coronary Prevention Evaluation Program
121. Hypertension Prevalence and the Status of Awareness Treatment and Control in the United States Final Report
122. Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats
123. Centrally acting hypotensive drugs
124. Effects of clonidine and guanfacine on drinking and ambulation in spontaneously hypertensive rats
125. Nifedipine effects on color match-to-sample performance in normotensive and renovascular hypertensive baboons
126. The effects of i.v. clonidine on blood pressure and heart rate in conscious baboons
127. Influence of antihypertensive drugs on psychosensory and psychomotor performance tests
128. The efficacy and safety of long-term antihypertensive therapy with nifedipine
129. Effects of angiotension converting enzyme inhibitors on the brain
130. Behavioural factors contribute to the development of spontaneous hypertension in rats
131. A comparison of the effects of atenolol and metoprolol on attention
132. Evaluation of the effect of atenolol on the reaction time of healthy volunteers
133. Captopril, blood pressure, and vascular reactivity in psychosocial hypertensive mice
134. Enhancement of human performance by caffeine and the amphetamines
135. Infusion of adrenergic receptor agonists and antagonists into the locus coeruleus and ventricular system of the brain: Effects on swim-motivated and spontaneous motor activity
136. Assessment of quality of life in clinical trials of cardiovascular therapies
137. The effects of acute and repeated clonidine administration on fixed-interval performance in rhesus monkeys
138. Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol
139. Comparative effects of propranolol and chlordiazepoxide anxiety states
140. Quality of life and its impact on hypertensive patients
141. Comparison of guanfacine versus clonidine for efficacy safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension
142. One-way generalization of clonidine to the discriminative stimulus produced by cocaine
143. Reinforcing properties of clonidine in rhesus monkeys
144. Patient Behavior for Blood Pressure Control
145. The effects of clonidine on food consumption and food competition in male stumptail macaques (Macaca arctoides)
146. Mood-elevating effect of captopril in depressed patients